SMCP (SMCP) H1 2024 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2024 earnings summary
2 Feb, 2026Executive summary
H1 2024 sales reached €585 million, down 3.6% organically year-over-year, with resilience in Europe and America offsetting a sharp decline in China and APAC; Sandro and Maje performed well outside China.
Sequential improvement was seen in Q2, especially in France and Europe, while digital sales remained above 20% of total.
Strict financial discipline led to net debt reduction to €293 million and a gross margin improvement to 74.3% of sales.
Sustainability initiatives resulted in a 15% CO2 emissions reduction from 2022 to 2023 and new Diversity & Inclusion policies.
Action plan targets a €25 million EBIT improvement by 2026, with ongoing digital, retail, and wholesale initiatives.
Financial highlights
Organic sales declined 3.6% year-over-year to €585 million; like-for-like sales fell 5.5%.
Adjusted EBIT was €19 million (3.2% margin), down from €36 million in H1 2023, impacted by restructuring and macro factors.
Net income was -€28 million, mainly due to €30 million in non-cash impairments and restructuring costs; breakeven before these items.
Free cash flow was -€8.8 million, stable year-over-year, supported by inventory and capex control.
Adjusted EBITDA margin decreased to 16.8% from 19.0% in H1 2023.
Outlook and guidance
H2 expected to benefit from more favorable comps starting August and positive reception of fall-winter collections.
Store closure plan in China to continue, with about 40 closures planned in H2, impacting sales more than in H1.
Network optimization and Claudie Pierlot repositioning to continue in H2 2024; retail partner activity to accelerate, including first openings in India and Southeast Asia.
Cost control measures underway, with some benefits expected in 2024 and more in 2025–2026.
EBIT improvement target of €25 million by 2026 reaffirmed.
Latest events from SMCP
- Record profitability, free cash flow, and margin gains in 2025, with 2026 guidance reaffirmed.SMCP
H2 202526 Feb 2026 - Sales fell 2.7% organically as China lagged, but Europe and America remained resilient.SMCP
Q3 2024 TU18 Jan 2026 - Resilient sales and strong cash flow set up margin recovery and €50m FCF by 2026.SMCP
H2 20247 Jan 2026 - Q1 2025 sales up 3.4% to €297m, gross margin rises, outlook cautious amid global uncertainties.SMCP
Q1 2025 TU27 Dec 2025 - 9M sales up 2.8% organically to €896m, led by EMEA and America, with APAC declining.SMCP
Q3 2025 TU13 Dec 2025 - Adjusted EBIT margin more than doubled and net income turned positive on strong H1 2025 results.SMCP
H1 202516 Nov 2025 - Resilient 2024 performance, global expansion, and strong RSE progress marked the AGM.SMCP
AGM 202513 Jun 2025